186 related articles for article (PubMed ID: 9403725)
41. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
Kondo H; Rabin BS; Rodnan GP
J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
[TBL] [Abstract][Full Text] [Related]
42. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.
Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF
Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269
[TBL] [Abstract][Full Text] [Related]
43. Altered CD4+ T cell and cytokine levels in peripheral blood and skin samples from systemic sclerosis patients and IL-35 in CD4+ T cell growth.
Yang C; Lei L; Pan J; Zhao C; Wen J; Qin F; Dong F; Wei W
Rheumatology (Oxford); 2022 Feb; 61(2):794-805. PubMed ID: 33878182
[TBL] [Abstract][Full Text] [Related]
44. Macrophage infiltration in the skin of patients with systemic sclerosis.
Ishikawa O; Ishikawa H
J Rheumatol; 1992 Aug; 19(8):1202-6. PubMed ID: 1404154
[TBL] [Abstract][Full Text] [Related]
45. Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?
De Palma R; D'Aiuto E; Vettori S; Cuoppolo P; Abbate G; Valentini G
Rheumatology (Oxford); 2010 Jul; 49(7):1257-66. PubMed ID: 20418226
[TBL] [Abstract][Full Text] [Related]
46. Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.
Ferrarini M; Steen V; Medsger TA; Whiteside TL
Clin Exp Immunol; 1990 Mar; 79(3):346-52. PubMed ID: 1969335
[TBL] [Abstract][Full Text] [Related]
47. Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine.
Fleischmajer R; Perlish JS; Shaw KV; Pirozzi DJ
Arch Dermatol; 1976 Nov; 112(11):1553-7. PubMed ID: 984860
[TBL] [Abstract][Full Text] [Related]
48. Endothelial cell renewal in skin of patients with progressive systemic sclerosis (PSS): an in vitro autoradiographic study.
Kazandjian S; Fiessinger JN; Camilleri JP; Dadoune JP; Housset E
Acta Derm Venereol; 1982; 62(5):425-9. PubMed ID: 6183893
[TBL] [Abstract][Full Text] [Related]
49. Skin resident memory T-cell population is not constructed effectively in systemic sclerosis.
Koguchi-Yoshioka H; Watanabe R; Fujisawa Y; Ishitsuka Y; Nakamura Y; Okiyama N; Fujimoto M
Br J Dermatol; 2019 Jan; 180(1):219-220. PubMed ID: 30120898
[No Abstract] [Full Text] [Related]
50. Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis.
Gruschwitz M; von den Driesch P; Kellner I; Hornstein OP; Sterry W
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):169-77. PubMed ID: 1430352
[TBL] [Abstract][Full Text] [Related]
51. Lymphocytotoxic and phagocytotoxic activity in progressive systemic sclerosis.
Pruzanski W; Lee P; Willshire A; Gladman D; Keystone EC
J Rheumatol; 1983 Feb; 10(1):55-60. PubMed ID: 6842486
[TBL] [Abstract][Full Text] [Related]
52. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis.
Maehara T; Kaneko N; Perugino CA; Mattoo H; Kers J; Allard-Chamard H; Mahajan VS; Liu H; Murphy SJ; Ghebremichael M; Fox D; Payne AS; Lafyatis R; Stone JH; Khanna D; Pillai S
J Clin Invest; 2020 May; 130(5):2451-2464. PubMed ID: 31990684
[TBL] [Abstract][Full Text] [Related]
53. [Interleukin 13 and interleukin 13 receptor involvement in systemic sclerosis].
Granel B; Chevillard C; Dessein A
Rev Med Interne; 2007 Sep; 28(9):613-22. PubMed ID: 17543424
[TBL] [Abstract][Full Text] [Related]
54. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease.
Giacomelli R; Cipriani P; Lattanzio R; Di Franco M; Locanto M; Parzanese I; Passacantando A; Ciocci A; Tonietti G
Clin Exp Immunol; 1997 Apr; 108(1):42-6. PubMed ID: 9097909
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.
Li L; Zhu H; Zuo X
Front Immunol; 2018; 9():2663. PubMed ID: 30498500
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration.
Kahaleh MB; LeRoy EC
Ann Intern Med; 1989 Mar; 110(6):446-50. PubMed ID: 2784042
[TBL] [Abstract][Full Text] [Related]
57. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma.
Duan H; Fleming J; Pritchard DK; Amon LM; Xue J; Arnett HA; Chen G; Breen P; Buckner JH; Molitor JA; Elkon KB; Schwartz SM
Arthritis Rheum; 2008 May; 58(5):1465-74. PubMed ID: 18438864
[TBL] [Abstract][Full Text] [Related]
58. Deep phenotyping detects a pathological CD4
Arbore G; Ong VH; Costantini B; Denton CP; Abraham D; Placais L; Blighe K; Mitchell L; Ellis R; Heck S; Nocerino P; Woodruff TM; Kordasti S; Kemper C; Hourcade DE
Cell Mol Immunol; 2020 Sep; 17(9):1010-1013. PubMed ID: 31974397
[No Abstract] [Full Text] [Related]
59. Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma.
Hunzelmann N; Anders S; Fierlbeck G; Hein R; Herrmann K; Albrecht M; Bell S; Thur J; Muche R; Adelmann-Grill B; Wehner-Caroli J; Gaus W; Krieg T
Arch Dermatol; 1997 May; 133(5):609-13. PubMed ID: 9158414
[TBL] [Abstract][Full Text] [Related]
60. "That's not helping-T follicular helper cells drive skin fibrosis".
Clark RA
Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29626172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
